UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.193

Sortiert nach

Wnt signaling controls radiosensitivity via cyclooxygenase‐2‐mediated Ku expression in head and neck cancer

International journal of cancer, 2008-01, Vol.122 (1), p.100-107

2008

Link zum Volltext

Verfügbarkeit prüfen

Intratendinous Ganglion of the Extensor Tendon of the Hand

Hand surgery, 2015-06, Vol.20 (2), p.316

2015

Link zum Volltext

Verfügbarkeit prüfen

EphA3 maintains radioresistance in head and neck cancers through epithelial mesenchymal transition

Cellular signalling, 2018-07, Vol.47, p.122-130

2018

Link zum Volltext

Verfügbarkeit prüfen

Percutaneous cerclage wiring followed by intramedullary nailing for subtrochanteric femoral fractures: a technical note with clinical results

Archives of orthopaedic and trauma surgery, 2014-09, Vol.134 (9), p.1227-1235

2014

Link zum Volltext

Verfügbarkeit prüfen

Radioresistant Cancer Cells Can Be Conditioned to Enter Senescence by mTOR Inhibition

Cancer research (Chicago, Ill.), 2013-07, Vol.73 (14), p.4267-4277

2013

Link zum Volltext

Verfügbarkeit prüfen

Exosome-guided direct reprogramming of tumor-associated macrophages from protumorigenic to antitumorigenic to fight cancer

Bioactive materials, 2023-07, Vol.25, p.527-540

2023

Link zum Volltext

Verfügbarkeit prüfen

EPHA3 Contributes to Epigenetic Suppression of PTEN in Radioresistant Head and Neck Cancer

Biomolecules (Basel, Switzerland), 2021-04, Vol.11 (4), p.599

2021

Link zum Volltext

Verfügbarkeit prüfen

Proteomic analysis of two head and neck cancer cell lines presenting different radiation sensitivity

Acta oto-laryngologica, 2008, Vol.128 (1), p.86-92

2008

Link zum Volltext

Verfügbarkeit prüfen

The prognostic value of hypoxia markers in T2-staged oral tongue cancer

Oral oncology, 2009-01, Vol.45 (1), p.63-68

2009

Link zum Volltext

Verfügbarkeit prüfen

Tristetraprolin Posttranscriptionally Downregulates TRAIL Death Receptors

Cells (Basel, Switzerland), 2020-08, Vol.9 (8), p.1851

2020

Link zum Volltext

Verfügbarkeit prüfen

Development of TRAIL Resistance by Radiation-Induced Hypermethylation of DR4 CpG Island in Recurrent Laryngeal Squamous Cell Carcinoma

International journal of radiation oncology, biology, physics, 2014-04, Vol.88 (5), p.1203-1211

2014

Link zum Volltext

Verfügbarkeit prüfen

Putative progenitor/stem cells isolated from human oral mucosa are resistant to ionizing radiation

Journal of dermatological science, 2008-04, Vol.50 (1), p.65-68

2008

Link zum Volltext

Verfügbarkeit prüfen

Antiangiogenic Activity of Orally Absorbable Heparin Derivative in Different Types of Cancer Cells

Pharmaceutical research, 2009-12, Vol.26 (12), p.2667-2676

2009

Link zum Volltext

Verfügbarkeit prüfen

Using YC-1 to overcome the radioresistance of hypoxic cancer cells

Oral oncology, 2009-10, Vol.45 (10), p.915-919

2009

Link zum Volltext

Verfügbarkeit prüfen

Peroxiredoxin IV Protects Cells From Radiation-Induced Apoptosis in Head-and-Neck Squamous Cell Carcinoma

International journal of radiation oncology, biology, physics, 2009-03, Vol.73 (4), p.1196-1202

2009

Link zum Volltext

Verfügbarkeit prüfen

The attenuation of experimental lung metastasis by a bile acid acylated-heparin derivative

Biomaterials, 2007-06, Vol.28 (16), p.2667-2676

2007

Link zum Volltext

Verfügbarkeit prüfen

Recurrence after endoscopic piecemeal mucosal resection for large sessile colorectal polyps

World journal of gastroenterology : WJG, 2010-06, Vol.16 (22), p.2806-2811

2010

Link zum Volltext

Verfügbarkeit prüfen

Expression of Ku80 correlates with sensitivities to radiation in cancer cell lines of the head and neck

Oral oncology, 2006-11, Vol.42 (10), p.979-986

2006

Link zum Volltext

Verfügbarkeit prüfen

Enhancer of zeste homolog 2 (EZH2)-dependent sirtuin-3 determines sensitivity to glucose starvation in radioresistant head and neck cancer cells

Cellular signalling, 2024-03, Vol.115, p.111029-111029, Article 111029

2024

Link zum Volltext

Verfügbarkeit prüfen

Albumin metabolism targeted peptide-drug conjugate strategy for targeting pan-KRAS mutant cancer

Journal of controlled release, 2022-04, Vol.344, p.26-38

2022

Link zum Volltext

Verfügbarkeit prüfen

Letter-to-editor, “Feedback amplification of senolysis using caspase-cleavable peptide-doxorubicin conjugate and 2DG” [Journal of Controlled Release, Volume 346, pp. 158-168, (2022), doi: 10.1016/j.jconrel.2022.04.012]

Journal of controlled release, 2023-10, Vol.362, p.779-783

2023

Link zum Volltext

Verfügbarkeit prüfen

Prolonged autophagy by MTOR inhibitor leads radioresistant cancer cells into senescence

Autophagy, 2013-10, Vol.9 (10), p.1631-1632

2013

Link zum Volltext

Verfügbarkeit prüfen

Feedback amplification of senolysis using caspase-3-cleavable peptide-doxorubicin conjugate and 2DG

Journal of controlled release, 2022-06, Vol.346, p.158-168

2022

Link zum Volltext

Verfügbarkeit prüfen

Metronomic oral doxorubicin in combination of Chk1 inhibitor MK-8776 for p53-deficient breast cancer treatment

Biomaterials, 2018-11, Vol.182, p.35-43

2018

Link zum Volltext

Verfügbarkeit prüfen

p53/BNIP3-dependent mitophagy limits glycolytic shift in radioresistant cancer

Oncogene, 2019-05, Vol.38 (19), p.3729-3742

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.193

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.083)
Mit Volltextzugriff
(1.132)

Publikationsform

Sprache

Englisch
(1.031)
Koreanisch
(160)
Japanisch
(140)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(22)
... seit 30 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Wnt signaling controls radiosensitivity via cyclooxygenase‐2‐mediated Ku expression in head and neck cancer

Intratendinous Ganglion of the Extensor Tendon of the Hand

EphA3 maintains radioresistance in head and neck cancers through epithelial mesenchymal transition

Percutaneous cerclage wiring followed by intramedullary nailing for subtrochanteric femoral fractures: a technical note with clinical results

Radioresistant Cancer Cells Can Be Conditioned to Enter Senescence by mTOR Inhibition

Exosome-guided direct reprogramming of tumor-associated macrophages from protumorigenic to antitumorigenic to fight cancer

EPHA3 Contributes to Epigenetic Suppression of PTEN in Radioresistant Head and Neck Cancer

Proteomic analysis of two head and neck cancer cell lines presenting different radiation sensitivity

The prognostic value of hypoxia markers in T2-staged oral tongue cancer

Tristetraprolin Posttranscriptionally Downregulates TRAIL Death Receptors

Development of TRAIL Resistance by Radiation-Induced Hypermethylation of DR4 CpG Island in Recurrent Laryngeal Squamous Cell Carcinoma

Putative progenitor/stem cells isolated from human oral mucosa are resistant to ionizing radiation

Antiangiogenic Activity of Orally Absorbable Heparin Derivative in Different Types of Cancer Cells

Using YC-1 to overcome the radioresistance of hypoxic cancer cells

Peroxiredoxin IV Protects Cells From Radiation-Induced Apoptosis in Head-and-Neck Squamous Cell Carcinoma

The attenuation of experimental lung metastasis by a bile acid acylated-heparin derivative

Recurrence after endoscopic piecemeal mucosal resection for large sessile colorectal polyps

Expression of Ku80 correlates with sensitivities to radiation in cancer cell lines of the head and neck

Enhancer of zeste homolog 2 (EZH2)-dependent sirtuin-3 determines sensitivity to glucose starvation in radioresistant head and neck cancer cells

Albumin metabolism targeted peptide-drug conjugate strategy for targeting pan-KRAS mutant cancer

Letter-to-editor, “Feedback amplification of senolysis using caspase-cleavable peptide-doxorubicin conjugate and 2DG” [Journal of Controlled Release, Volume 346, pp. 158-168, (2022), doi: 10.1016/j.jconrel.2022.04.012]

Prolonged autophagy by MTOR inhibitor leads radioresistant cancer cells into senescence

Feedback amplification of senolysis using caspase-3-cleavable peptide-doxorubicin conjugate and 2DG

Metronomic oral doxorubicin in combination of Chk1 inhibitor MK-8776 for p53-deficient breast cancer treatment

p53/BNIP3-dependent mitophagy limits glycolytic shift in radioresistant cancer

Suchergebnisse filtern